Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Articles from our Partners at Consultant 360 October 2019

New Respiratory Disease Articles from our Partners at Consultant 360

Procalcitonin-Guided Therapy Significantly Reduces Antibiotics Duration

http://bit.ly/2mlQWeb

Authors of a new study investigated whether monitoring procalcitonin can safely and effectively decrease antibiotic exposure in patients with ventilator-associated pneumonia.

FDA Approves First Treatment Option for Patients With SSc-ILD

http://bit.ly/2owxDPR

Previously to this drug’s approval, there were no treatment options for adults with interstitial lung disease associated with systemic sclerosis or scleroderma.

In Asthma, Blood Eosinophil Counts Remain Lower After Systemic Corticosteroid Discontinuation

http://bit.ly/2mif0hS

While it is known that systemic corticosteroids reduce blood eosinophil counts in patients with asthma, authors of a new study sought to determine whether the therapy affects the counts over time.

Diagnosing Pulmonary Fibrosis Early Is Key

http://bit.ly/2mmIGKU

In this commentary, Albert Rizzo, MD, outlines diagnostic steps, treatment options, and possibility of a cure for pulmonary fibrosis.

3 Questions About CV Outcomes in Patients With OSA

http://bit.ly/2nVONWK

Diego R. Mazzotti, PhD, answered our questions about his study on cardiovascular outcomes related to obstructive sleep apnea symptom subtypes.